Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

nusinersen

- PMLiVE

Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)

How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch

Innovative Trials

Biogen Idec building

Biogen’s Aduhelm unlikely to get approval in Europe

In another setback for the controversial Alzheimer’s disease antibody, the EMA’s review committee has voted against recommending the treatment

- PMLiVE

Six ways to improve diversity in clinical trials

Diversity is becoming increasingly important as a focus of clinical trials. This whitepaper gives six approaches that could be implemented to help make diversity a bigger focus on your clinical...

Innovative Trials

- PMLiVE

Eisai/Biogen present more data on antibody for Alzheimer’s disease

Phase 2 data shows lecanemab offers a consistent ‘robust’ effect against Alzheimer’s disease, while the phase 3 programme will test plasma biomarkers to identify preclinical disease

Biogen Idec building

Biogen investigating death linked to Aduhelm

The death of a 75-year-old patient taking Biogen’s Aduhelm has raised yet more questions around the recently approved Alzheimer’s therapy

Making Actionable Health Information More Accessible Through Point-of-Care Testing

Hector Bremner, CEO of Avricore Health, discusses the benefits of comprehensive point-of-care testing for patient monitoring, real-world studies, and decentralized clinical trials; how his company is working on becoming the...

Impetus Digital

- PMLiVE

Men’s Health Awareness Month

In this November blog, Innovative Trials will be looking at the men's health and the Movember movement which aims at raising awareness around men's health

Innovative Trials

Unlocking the Potential of Electronic Medical Records Using Artificial Intelligence

Dr. Javier Mendoza, Gastroenterologist and Digital Health Expert, explores digital health in medicine and clinical research, natural language processing, the ethics surrounding AI, and his experience as a medical doctor...

Impetus Digital

Biogen Idec building

Biogen’s ALS drug tofersen misses phase 3 endpoint

Following these results, Biogen will now expand its early access programme for tofersen to enable all eligible SOD1-ALS patients worldwide to receive the drug free of charge

Biogen Idec building

Data shows patients treated with Biogen’s MS therapies mount an effective antibody response to COVID-19 vaccination

New MS PATHS data was presented at ECTRIMS 2021

- PMLiVE

Lupus Awareness Month

In this second October’s blog, we will be looking into Lupus in clinical trials: its symptoms, complications, treatments, incidence and focus on diversity.

Innovative Trials

- PMLiVE

Black community representation in clinical trials

This Black History Month, we discuss the black representation in clinical trials and the effects COVID-19 has had on the black community.

Innovative Trials

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links